Press Releases
Novartis, Voyager Therapeutics reach license option agreement for next-generation gene therapy vectors for neurological diseases
Novartis announced a license option agreement with Voyager Therapeutics, a gene therapy company focused on next-generation adeno-associated virus (AAV) technologies, for three capsids to...
Drug Research
Vibalogics Completes Major Milestone in $50M Cuxhaven Facility Expansion with New 500L Manufacturing Line
Vibalogics, a leading virotherapy contract development and manufacturing organization (CDMO) focused on the production of live– viruses and viral vectors, has announced the completion...
News
Alcami Adds Additional Formulation Development Capabilities
Alcami, a U.S.-based pharmaceutical contract development and manufacturing organization (CDMO), announced the addition of a 3,800 ft² Non-GMP Formulation Development Laboratory (FDL). The dedicated...
Press Releases
Thermo Fisher Scientific Launches New GC/GC-MS Instrument Portfolio for Increased Efficiency
Thermo Fisher Scientific Inc., the world leader in serving science, enables analytical testing laboratories across a variety of sectors, including food, environmental, industrial and...
News
Moderna Chooses Kenya For $500M mRNA Manufacturing Factory
Moderna chose Kenya as its location for a $500 million African mRNA vaccine manufacturing effort. The pharmaceutical company says it signed a letter of...
News
U.S. FDA Approves Opdivo with Chemotherapy as Neoadjuvant Treatment for Certain Adult Patients with Resectable Non-Small Cell Lung Cancer
Bristol Myers Squibb announced that the U.S. FDA approved Opdivo®(nivolumab) 360 mg (injection for intravenous use) in combination with platinum-doublet chemotherapy every three weeks...
Drug Research
Orbit Discovery and WuXi AppTec sign agreement to access peptide discovery and optimisation technologies
Orbit Discovery (Orbit), a ground-breaking peptide discovery company is pleased to announce the commencement of a partnership with WuXi AppTec, a leading global provider...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read